Abaxis Inc (ABAX) 47.11 $ABAX Point of Care (PoC) Lipid

New Post Public Reply Private Reply Replies (0) Message Board

Jun 24, 2016 at 6:13 AM

Abaxis Inc (ABAX) 47.11 $ABAX

Point of Care (PoC) Lipid Test Market Size & Forecast By Instruments (Brand Market Sizing: Roche Reflotron, Roche Cobas b 101, Abaxis Piccolo, Alere Cholestech LDX, Alere Afinion, Samsung LABGEO, PTS CardioChek), By Application (Hyperlipidemia, Hypertrigl
PR Newswire - Wed Jun 22, 4:33PM CDT
Global Point of care (PoC) Lipid Test market is expected to reach USD 280.02 million by 2022 according to a new report by Grand View Research Inc. Growing geriatric population base, increasing global prevalence of cardiovascular diseases, and rising healthcare awareness due to patient education are the driving forces for the PoC Lipid Test industry growth during the forecast period.
ABAX: 47.11 (+1.81)

Abaxis Global Diagnostics and AAHA Develop Preventive Care Testing Initiative
PR Newswire - Mon Jun 06, 7:00AM CDT
Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, today announced a partnership with the American Animal Hospital Association (AAHA) to develop a wellness testing initiative that is focused on improving compliance for blood diagnostic testing.
ABAX: 47.11 (+1.81)

Abaxis (ABAX): Solid Veterinary Show Despite Global Hiccups
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 5:01AM CDT
On Jun 3, 2016, we issued an updated research report on Abaxis, Inc. (ABAX). The stock currently carries a Zacks Rank #4 (Sell).
ICUI: 108.13 (+3.15), ABAX: 47.11 (+1.81), LMAT: 14.82 (+0.13), NUVA: 58.86 (+1.07)

Abaxis, Inc. to Present at the Jefferies 2016 Global Healthcare Conference
PR Newswire - Wed Jun 01, 7:02AM CDT
Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, announced today that Ross Taylor, chief financial officer, will present at the Jefferies 2016 Global Healthcare Conference on Tuesday, June 7, 2016 at 10:30 a.m. ET. The conference will be held at the Grand Hyatt in New York City.
ABAX: 47.11 (+1.81)

New Strong Sell Stocks for May 31st
Swarup Gupta - Zacks Investment Research - Tue May 31, 8:27AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Tuesday
ABAX: 47.11 (+1.81), ASB: 18.19 (+0.66), AHT: 5.58 (+0.13), CIT: 32.19 (+0.98), MATX: 34.15 (+0.87)

Abaxis, Inc. to Present at the Stifel 2016 Dental & Veterinary Conference
PR Newswire - Wed May 25, 7:00AM CDT
Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, announced today that Ross Taylor, chief financial officer, will present at the Stifel 2016 Dental & Veterinary Conference on Wednesday, June 1, 2016 at 8:00 a.m. ET. The conference will be held at The Peninsula Hotel in New York City.
ABAX: 47.11 (+1.81)

Abaxis (ABAX) Posts Solid Q4 amid International Headwind
Zacks Equity Research - Zacks Investment Research - Wed May 25, 5:28AM CDT
On May 18, 2016, we issued an updated research report on Abaxis, Inc. (ABAX).
ICUI: 108.13 (+3.15), ABAX: 47.11 (+1.81), LMAT: 14.82 (+0.13), NUVA: 58.86 (+1.07)

New Strong Sell Stocks for May 12th
Zacks Equity Research - Zacks Investment Research - Thu May 12, 6:59AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Thursday
ABC: 77.55 (+0.42), ABAX: 47.11 (+1.81), AMID: 12.32 (+0.12), ABBV: 61.31 (+0.92), FCCY: 12.15 (-0.12)

Global Biochip Market Worth USD 18.4 Billion by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Key Vendors: 3Qbd, Abaxis Inc, Emulate Inc - Research and Markets
BusinessWire - Thu May 05, 4:36AM CDT
Research and Markets has announced the addition of the "Global Biochip Markets: Microarrays and Lab-on-a-Chip" report to their offering.
ABAX: 47.11 (+1.81)

Abaxis (ABAX) Q4 Earnings Beat Estimates; Dividend Raised
Zacks Equity Research - Zacks Investment Research - Fri Apr 29, 9:21AM CDT
Abaxis, Inc. (ABAX) reported fourth-quarter fiscal 2016 earnings per share (EPS) of 36 cents from continuing operations.
BSX: 22.97 (+0.31), CAPR: 4.38 (+0.11), CSII: 17.90 (+0.36), ABAX: 47.11 (+1.81)

Abaxis tops Street 4Q forecasts
Automated Insights - Thu Apr 28, 4:49PM CDT
UNION CITY, Calif. (AP) _ Abaxis Inc. (ABAX) on Thursday reported fiscal fourth-quarter earnings of $8.9 million.
ABAX: 47.11 (+1.81)

Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2016 and Declares a 9% Increase in Quarterly Cash Dividend
PR Newswire - Thu Apr 28, 3:01PM CDT
Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, today reported financial results for the fourth quarter and fiscal year ended March 31, 2016.
ABAX: 47.11 (+1.81)

Abaxis To Report Fourth Quarter And Fiscal Year 2016 Financial Results On Thursday, April 28, 2016
PR Newswire - Tue Apr 19, 7:00AM CDT
Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care instruments and consumables for the medical, research, and veterinary markets, has scheduled a conference call to discuss its financial results for the fourth quarter and fiscal year 2016, ended March 31, 2016. The call will be at 4:15 p.m. ET on Thursday, April 28, 2016. The Company will report financial results for the fourth quarter and fiscal year 2016 after the market closes on Thursday, April 28, 2016.
ABAX: 47.11 (+1.81)

Global Veterinary Diagnostics Market Report 2014-2022 - Analysis, Technologies & Forecasts - Key Vendors: Abaxis, HESKA, IDEXX Labs - Research and Markets
BusinessWire - Tue Apr 12, 7:26AM CDT
Research and Markets has announced the addition of the "Veterinary Diagnostics Global Market Analysis - Forecast (2014-2022)" report to their offering.
ABAX: 47.11 (+1.81)

Global Blood Gas and Electrolyte Analyzer Industry
PR Newswire - Mon Apr 04, 6:43PM CDT
This report analyzes the worldwide markets for Blood Gas and Electrolyte Analyzers in Units and US$ Thousand by the following Product Segments: Blood Gas Analyzers (Benchtop Analyzers, & Point-of-Care Analyzers), and Electrolyte Analyzers. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 42 companies including many key and niche players such as -
ABAX: 47.11 (+1.81)

23.6% Return Seen to Date on SmarTrend Abaxis Call (ABAX)
Comtex SmarTrend(R) - Wed Mar 02, 11:51AM CST
SmarTrend identified a Downtrend for Abaxis (NASDAQ:ABAX) on January 11th, 2016 at $51.04. In approximately 2 months, Abaxis has returned 23.63% as of today's recent price of $38.98.
ABAX: 47.11 (+1.81)

Abaxis Down 21.1% Since SmarTrend Downtrend Call (ABAX)
Comtex SmarTrend(R) - Mon Feb 08, 4:31PM CST
SmarTrend identified a Downtrend for Abaxis (NASDAQ:ABAX) on January 11th, 2016 at $51.04. In approximately 4 weeks, Abaxis has returned 21.14% as of today's recent price of $40.25.
ABAX: 47.11 (+1.81)

Abaxis Down 13.2% Since SmarTrend Downtrend Call (ABAX)
Comtex SmarTrend(R) - Mon Feb 01, 11:43AM CST
SmarTrend identified a Downtrend for Abaxis (NASDAQ:ABAX) on January 11th, 2016 at $51.04. In approximately 3 weeks, Abaxis has returned 13.19% as of today's recent price of $44.31.
ABAX: 47.11 (+1.81)

Abaxis Reports Financial Performance for the Third Quarter of Fiscal 2016, Declares Quarterly Cash Dividend
PR Newswire - Thu Jan 28, 3:00PM CST
Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, today reported financial results for the third fiscal quarter ended December 31, 2015.
ABAX: 47.11 (+1.81)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

U.S. Millionaire Surge: Market Waves or Mirage?

Flashing Billions: Minting Millionaires at Breakneck Speed It sounds like something out of an 80s movie: every single day, over 1,200 folks in the United States become millionaires. Yep, you heard right. The UBS Global Wealth Report 2026 threw that number out, and it sure caught my attention. It's not everyday you hear about the U.S. cranking out millionaires like they're...

Plata Hits $1 Billion ARR in Record Digital Bank Growth

Plata Rocks the Boat with Rapid Revenue Growth When a digital bank like Plata rakes in $1 billion in Annual Recurring Revenue (ARR) within just 3.5 years, you can't just shrug it off. That's blazing fast by any standard, especially for a financial institution. Emerging from Mexico, this bank's rocket-like ascent is flinging the doors wide open for what's possible in the...

Netcapital Faces Securities Fraud Claims: Key Investor Notes

Netcapital Under Fire: The Suit Unfolds You ever see a stock go through such highs and lows that you wish you had popcorn on standby? Well, that's where Netcapital Inc. (NASDAQ: NCPL) is sitting right now, in the midst of a class action lawsuit that's got investors' heads spinning. The accusations are serious: false and misleading statements about revenues that seem to...

Cruise Planners Sets AI Benchmark in Travel Innovs

Unveiling the AI Arsenal of Cruise Planners Alright, listen up, folks. When you think about travel and tech, Cruise Planners ain't just dipping a toe—they're cannonballing right in, splashing everyone around with their shiny new AI tricks. Twenty-three. That's how many innovations they're flaunting this year. It's like they're running a tech marathon, and boy, are they...

Taiwan Excellence Sparks Smart Automotive Innovation at SEMA

Taiwan's making waves, folks, and it's not your everyday splash in the automotive pool. At SEMA 2026, Taiwan Excellence Pavilion is the place to be with its array of intelligent automotive solutions. This ain't just your run-of-the-mill car show gimmickry—it's the future rolling in real-time. Driving Innovation: From Components to Smart Systems The name of the game is...

Art Print Paper: Finding the Perfect Match for Masterpieces

You ever stand in a gallery and notice how some art just lights up the room while others barely get a second glance? Well, a lot of that magic starts with an unsung hero—paper choice. I came across this bit from HelloNation diving into what makes paper selection a cornerstone for fine art prints. Now, I ain't an artist, but even a bruiser trader like me can see the...

Noé Hinojosa Jr. Honored for Leadership in Business

From Bonds to Ballgames: Hinojosa's Impact Listen up, because this one’s more than just another accolade on a shelf. Noé Hinojosa Jr., a big gun over at TRB Securities, is getting the 2026 Hispanic Business Salute Award, and it's a doozy. Awarded by all the big wigs—UPS, NBC 5, Telemundo 39, and the Dallas Cowboys—this isn't a small pat on the back. It's a full-on...

Decoding Love: The Real Patterns of Relationships

The Relationship Maze: More Than Meets the Eye Love ain't just a simple spark over a fancy dinner, let me tell you. In Dr. Bernadette Marson’s ‘The Relationship Code,’ she digs into seventy-seven elements gnawing at why relationships can crumble or thrive. It’s like a blueprint of human entanglements—a veritable explorer’s guide to the vast, wild creation we...

2GenPen & LordCap Team Up: Game-Changer in ABS?

New Kids on the Structured Credit Block? Well, it looks like we're in for a ride with 2GenPen teaming up with Lord Capital to shake up the asset-backed securities (ABS) world. They're strutting their stuff by launching a strategic collaboration to boost credit analysis. Think of it as a power-up for ABS transactions—because nobody loves a murky credit rating. The Heart...

Richard Huffman Joins IFA Board, Strengthens Franchise Ties

Ever wonder how the cogs in this massive machine called franchising keep turning? It's folks like Richard Huffman who step up to the plate, and his recent election to the International Franchise Association (IFA) Board of Directors is worth a second glance. Huffman: A Franchise Veteran Now, Huffman isn't some rookie in the world of franchising. You see, back in '94, he...